FDA-approved Anticancer Drug Library

Kat.-Nr.L8000

Eine einzigartige Sammlung von 1728 zugelassenen Medikamenten mit potenzieller Antikrebsaktivität, die für Hochdurchsatz-Screening (HTS) und High-Content-Screening (HCS) verwendet werden.

96 well plates

Passen Sie Ihre Bibliothek an:

Zitiert von 327 Publikationen

Beschreibung & Vorteile

•A unique collection of 1728 approved drugs with potential anticancer activity used for high throughput screening(HTS) and high content screening(HCS);
 
•All drugs were from approved institutions such as FDA,EMA,HMA,CFDA,PMDA,or pharmacopoeia such as USP,BP,EP,JP,Ph.Int,etc;
 
 •Bioactivity and safety confirmed by clinical trials; 
 
• Structurally diverse, medicinally active, and cell permeable;
 
• Rich documentation with structure and customer reviews;
 
• NMR and HPLC validated to ensure high purity. 

Produktdetails

Formulierung 1554 compounds pre-dissolved in 10mM DMSO, 111 compounds pre-dissolved in 10mM water, 54 compounds pre-dissolved in 2mM DMSO and 9 compounds pre-dissolved in 2mM water
Behälter 96 Deep-Well-Platte mit Aluminiumfolie versiegelt
Stabilität 12 months -20°C in DMSO
24 months -80°C in DMSO
Versand Kühlakku oder Trockeneis

Fallstudien mit Selleck Compound-Bibliotheken

FDA-approved Anticancer Drug Library Zusammensetzung

HTS-Anlagenpartner

  • Collaborating with Seleck: Yale University | Yale Center for Molecular Discovery
  • Collaborating with Seleck: Carbone Cancer Center | University of Wisconsin-Madison
  • Collaborating with Seleck: University of Colorado Denver | CU Denver
  • Collaborating with Seleck: Leibniz-Forschungsinstitut für Molekulare Pharmakologie: Leibniz-FMP
  • Collaborating with Seleck: UCSF_University of California San Francisco
  • Collaborating with Seleck: KU | High Throughput Screening Laboratory
  • Collaborating with Seleck: CIBIO
  • Collaborating with Seleck: Perelman school of medicine | University of Pennsylvania